You searched for lung cancer | Page 50 of 166

FDA Approves VENTANA PD-L1 as a CDx for NSCLC Subtype

Posted by Andy Lundin | Mar 9, 2023 | Lung Cancer |

The FDA approved the VENTANA PD-L1 (SP263) Assay as a CDx to identify NSCLC patients eligible for treatment with Libtayo (cemiplimab).

Posted by Andy Lundin | Mar 9, 2023 | Leukemia |

Research shows benefits of screening patients in remission from acute myeloid leukemia for residual disease prior to a bone marrow transplant.

Posted by Andy Lundin | Mar 3, 2023 | Urine Analyzers |

Researchers developed a urine sensor that can amplify the light signal of metabolites in urine and in diagnosing cancer in the field.

Automated NGS platforms can help determine if a patient is fit for a targeted therapy, enabling more effective precision medicine.

Veracyte CEO Marc Stapley outlines how single-cancer testing is giving pathologists, clinicians, and patients an edge.